FDA sought policy recommendations on mental health medical devices, including AI-enabled. After I reviewed submissions, one caught my attention. An AI Insider perspective.

Capricor Therapeutics faces high regulatory risks for its DMD therapy. Get expert analysis on trial data and FDA challenges.

Opinion: Researchers from the Oxford Internet Institute argue that lessons from social sciences can help us better assess the ...

The number of published studies using the Delphi method has increased considerably in recent years. The Delphi method is now ...

Just three months ago, Zimbabwe’s GDP was suddenly revised from US$35.2 billion to US$44.4 billion — an extraordinary jump of ...

The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional ...

Discover how the Workflow Management System Market is evolving, driven by cloud adoption and smart automation to reach USD 70 ...

Palantir Technologies Inc. posted strong Q3 growth and a high R40 score, signaling scalability amid high valuations. Click ...

Objectives To evaluate the available virtual reality (VR) applications for treating perinatal mental health disorders, focusing on their effectiveness in reducing symptoms such as anxiety and ...

Discover industrial container recycling and reconditioning benefits: cost savings up to 70%, reduced carbon footprint, and ...

Police said they will question those who evaded public inquiry and named former legal boss Jane MacLeod as example ...

The term ‘dependant’ in the immigration system misrepresents migrant family realities and reinforces outdated gendered ...